Please login to the form below

Not currently logged in
Email:
Password:

The Netherlands

This page shows the latest The Netherlands news and features for those working in and with pharma, biotech and healthcare.

EMA sees approval numbers rise in 2018

EMA sees approval numbers rise in 2018

The greatest risk to the EMA’s business continuity is staff leaving the agency rather than relocate with it to the Netherlands, though it recently said projections that departures have not ... Lastly, the EMA’s key human medicines committee, the CHMP,

Latest news

More from news
Approximately 3 fully matching, plus 159 partially matching documents found.

Latest Intelligence

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    10.8% of GDP is spent on healthcare in the Netherlands versus 9.8% in the UK. ... Since the Netherlands is among the five wealthiest countries in the eurozone, the Dutch have high expectations.

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    The progress, in human and medical terms, has been profound and the 22. ... nd. International AIDS conference held in the Netherlands in July and attended by 15, 000 global policy makers, researchers and advocates, had a very different mood to its first,

  • Delivering real patient value Delivering real patient value

    We refer to this approach as Patient Value Planning. 1. Start with the patient. ... Anna Georgieva is programme director at Excerpta Medica, Amsterdam, The Netherlands and Dominic Sloane is business development director at Adelphi Communications,

  • Biologic or biosimilar: what are prescribers thinking? Biologic or biosimilar: what are prescribers thinking?

    The results revealed consistent attitudes regarding several key issues that affect prescribing behaviour. ... is senior research manager at SKIM Healthcare in the Netherlands, a.denhollander@skimgroup.com.

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    the Netherlands show an underlying fragility in the political foundations of some of Europe’s biggest economies. ... the actual date of departure is likely to be in the early 2020s.

More from intelligence
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest appointments

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    Novartis as well as heading their clinical operations team in the Netherlands. ... in the vascular calcification space and fine-tune our clinical strategy in view of first-in-human studies in 2019.”.

  • Bayer appoints Wolfgang Nickl as chief financial officer Bayer appoints Wolfgang Nickl as chief financial officer

    He will succeed Johannes Dietsch on June 1, 2018. Bayer has appointed a new chief financial officer in the form of Wolfgang Nickl, who will take over from Johannes Dietsch on ... Nickl has already been the CFO of several companies in the United States

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    Verwiel has also served at Merck &Co, where he was vice president and was general manager at Merck Sharpe Dohme’s operations in the Netherlands. ... They bring decades of scientific, operational, business and strategic experience in the pharmaceutical

  • Hywel Day joins Napp Pharmaceuticals Hywel Day joins Napp Pharmaceuticals

    At that company he served in a general manager role, based in The Netherlands, where he led the business through a substantial transformation, which involved a significant cultural shift and a ... on our promises to the NHS, patients, our business

  • uniQure appoints chief executive officer uniQure appoints chief executive officer

    Based in the Netherlands and the US, uniQure has appointed Matthew Kapusta as its chief executive officer. ... This is an exciting time for uniQure, and I am fully committed to the company's success and the execution of our core strategic goals.

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics